Ironwood Pharmaceuticals
IRWD
IRWD
151 hedge funds and large institutions have $2.69B invested in Ironwood Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 52 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less capital invested
Capital invested by funds: $2.85B → $2.69B (-$157M)
15% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 52
Holders
151
Holding in Top 10
3
Calls
$21.8M
Puts
$10.7M
Top Buyers
| 1 | +$11.5M | |
| 2 | +$9.24M | |
| 3 | +$9.23M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$8.98M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$8.79M |
Top Sellers
| 1 | -$41.4M | |
| 2 | -$21.7M | |
| 3 | -$20.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.3M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$17.8M |